Markus J. Cappel, Chief Business Officer & Treasurer at ChemoCentryx, Inc. (CCXI), sold 17,650 shares at $67.14 ($1.2M) on 2021-02-04, disclosed to the SEC on 2021-02-08.
Open-market sale of $1.2M CCXI by Chief Business Officer & Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.14 | 1,400 | $94K | 7.9% |
| 2 | $67.07 | 805 | $54K | 4.5% |
| 3 | $67.07 | 805 | $54K | 4.5% |
| 4 | $67.28 | 7,220 | $486K | 40.9% |
| 5 | $67.28 | 7,220 | $486K | 40.9% |
| 6 | $68.00 | 200 |
| $14K |
| 1.1% |
| Total | $67.26 avg | 17,650 | $1.2M | 100% |
| Filing → |
| CCXI | SELL | 2021-02-11 | $49K | — | Filing → |
| CCXI | SELL | 2021-01-27 | $184K | — | Filing → |
| CCXI | SELL | 2020-06-16 | $4.4M | — | Filing → |